ENTITY
Mesoblast Ltd

Mesoblast Ltd (MSB AU)

45
Analysis
Health CareAustralia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
12 Jun 2020 11:25

ASX200 Index Review - A Handful of Changes

S&P Dow Jones Indices announced changes to the S&P/ASX 200 (AS51 INDEX) today. The changes are effective at the open of trading on 22 June...

Logo
484 Views
Share
05 Sep 2019 14:55

Australia Short Interest - August in Review

Of the 134 companies that reported annual results in August, 65% missed their targets on the top line and just over half reported a rise in profits...

Logo
457 Views
Share
bullishMesoblast Ltd
13 Jul 2018 10:59

Raising FVE for Mesoblast After Adjusting for AUD as We Await 180 Day Survival Data in AGvHD

We are raising our fair value estimate for no-moat Mesoblast Ltd (MSB AU) to AUD 2.90 from AUD 2.60 previously, after adjusting for the recent...

Logo
410 Views
Share
bullishMesoblast Ltd
01 Mar 2018 09:03

Mesoblast Books First-Half Profit and Moves Closer to FDA Approval in Pediatric AGvHD

No-moat Mesoblast Ltd (MSB AU) achieved a financial milestone in the first six months of fiscal 2018 by posting a maiden net profit after tax of...

Logo
130 Views
Share
05 Jan 2018 09:35

Human Longevity

At KIS capital we try to keep ourselves at the forefront of technology and innovation, attempting to identify which industries may blossom, and...

Share
x